Factor concentrates in trauma

Current Opinion in Anaesthesiology

Volumn 28, Issue 2, 2015, Pages 217-226

  Tobin, Joshua M ^a   Tanaka, Kenichi A ^b   Smith, Charles E ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

fibrinogen; prothrombin complex concentrate; viscoelastic testing

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; FIBRINOGEN; PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR;

BLOOD CLOTTING; BLOOD TRANSFUSION; CARE BUNDLE; FLUID RESUSCITATION; HUMAN; INJURY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; POINT OF CARE TESTING; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY; VISCOELASTICITY; BLOOD; DRUG EFFECTS; PATHOPHYSIOLOGY; WOUNDS AND INJURIES;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; HUMANS; WOUNDS AND INJURIES;

EID: 84926387778     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000167     Document Type: Review

References (40)

1. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008; 65: 748-754.
2. Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11: 307-314.
3. Yuan S, Ferrell C, Chandler WL. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res 2007; 120: 29-37.
4. Sankarankutty A, Nascimento B, Teodoro da Luz L, Rizoli S. TEG(R) and ROTEM(R) in trauma: similar test but different results? World J Emerg Surg 2012; 7 (Suppl 1): S3.
5. Da Luz LT, Nascimento B, Rizoli S. Thrombelastography (TEG(R)): practical considerations on its clinical use in trauma resuscitation. Scand J trauma Resusc Emerg Med 2013; 21: 29.
6. Cotton BA, Faz G, Hatch QM, et al. Rapid thrombelastography delivers realtime results that predict transfusion within 1 h of admission. J Trauma 2011; 71: 407-414.
7. Davenport R, Manson J, De'Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652-2658.
8. Holcomb JB, Minei KM, Scerbo ML, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256: 476-486.
9. Nascimento B, Al Mahoos M, Callum J, et al. Vitamin K-dependent coagulation factor deficiency in trauma: a comparative analysis between international normalized ratio and thromboelastography. Transfusion 2012; 52: 7-13.
10. Pham HP, Shaz BH. Update on massive transfusion. B J Anaesth 2013; 111 (Suppl 1): i71-i82.
11. Fries D. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. Transfusion 2013; 53 (Suppl 1): 91S-95S.
12. Da Luz LT, Nascimento B, Shankarakutty AK, et al. Effect of thromboelastography (TEG(R)) and rotational thromboelastometry (ROTEM(R)) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review. Crit Care 2014; 18: 518.
13. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17: R76.
14. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfus Med Rev 2003; 17: 223-231.
15. Berube C. Disorders of fibrinogen. UpToDate ; http://www.uptodate.com/contents/disorders-of-fibrinogen. [Accessed 15 October 2014]
16. Schochl H, Schlimp CJ. Trauma bleeding management: the concept of goaldirected primary care. Anesth Analg 2014; 119: 1064-1073.
17. Tanaka KA, Esper S, Bolliger D. Perioperative factor concentrate therapy. Br J Anaesth 2013; 111 (Suppl 1): i35-i49.
18. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesth Analg 2012; 114: 261-274.
19. Gollop ND, Chilcott J, Benton A, et al. National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemia. Transfus Med 2012; 22: 350-355.
20. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64 (2 Suppl): S79-S85.
21. McSwain N Jr, Barbeau J. Potential use of prothrombin complex concentrate in trauma resuscitation. J Trauma 2011; 70 (5 Suppl): S53-S56.
22. Ferreira J, DeLosSantos M. The clinical use of prothrombin complex concentrate. J Emerg Med 2013; 44: 1201-1210.
23. Holland L, Warkentin TE, Refaai M, et al. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion 2009; 49: 1171-1177.
24. Dickneite G, Dorr B, Kaspereit F, Tanaka KA. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma 2010; 68: 1151-1157.
25. Porta CR, Nelson D, McVay D, et al. The effects of tranexamic acid and prothrombin complex concentrate on the coagulopathy of trauma: an in vitro analysis of the impact of severe acidosis. J Trauma Acute Care Surg 2013; 75: 954-960.
26. Joseph B, Aziz H, Pandit V, et al. Improving survival rates after civilian gunshot wounds to the brain. J Am Coll Surg 2014; 218: 58-65.
27. Huynh TK, Costello JL, Rebuck JA. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy. Pharmacotherapy 2014; 34: 260-264.
28. Joseph B, Hadjizacharia P, Aziz H, et al. Prothrombin complex concentrate: an effective therapy in reversing the coagulopathy of traumatic brain injury. J Trauma Acute Care Surg 2013; 74: 248-253.
29. Joseph B, Aziz H, Pandit V, et al. Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference? World J Surg 2014; 38: 1875-1881.
30. Joseph B, Amini A, Friese RS, et al. Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg 2012; 72: 828-834.
31. Pabinger I, Brenner B, Kalina U, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 2008; 6: 622-631.
32. Freeman WD, Aguilar MI, Weitz J. Reversal of anticoagulation in warfarinassociated intracerebral hemorrhage. UpToDate 2014; http://www.uptodate. com/contents/reversal-of-anticoagulation-in-warfarin-associated-intracerebralhemorrhage. [Accessed 15 October 2014]
33. Fries D, Haas T, Klingler A, et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy-a porcine model. B J Anaesth 2006; 97: 460-467.
34. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
35. Innerhofer P, Westermann I, Tauber H, et al. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44: 209-216.
36. Lockey DJ, Weaver AE, Davies GE. Practical translation of hemorrhage control techniques to the civilian trauma scene. Transfusion 2013; 53 (Suppl 1): 17S-22S.
37. Schochl H, Maegele M, Solomon C, et al. Early and individualized goaldirected therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20: 15.
38. Schochl H, Schlimp CJ, Voelckel W. Potential value of pharmacological protocols in trauma. Curr Opin Anaesthesiol 2013; 26: 221-229.
39. Hilbert P, Hofmann GO, Teichmann J, et al. The "coagulation box" and a new hemoglobin-driven algorithm for bleeding control in patients with severe multiple traumas. Arch Trauma Res 2013; 2: 3-10.
40. Lippi G, Favaloro EJ, Cervellin G. Massive posttraumatic bleeding: epidemiology, causes, clinical features, and therapeutic management. Semin Thromb Hemost 2013; 39: 83-93.